These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15086354)

  • 1. Why HDL cholesterol is 'good cholesterol'.
    van der Giet M; Tölle M
    Eur J Clin Invest; 2004 Apr; 34(4):247-8. PubMed ID: 15086354
    [No Abstract]   [Full Text] [Related]  

  • 2. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations].
    Birjmohun RS; van der Steeg WA; Stroes ES; Kastelein JJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2245-50. PubMed ID: 17076358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
    Nachtigal P; Kopecky M; Solichova D; Zdansky P; Semecky V
    J Pharm Pharmacol; 2005 Feb; 57(2):197-203. PubMed ID: 15720783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
    Chapman MJ
    Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport.
    Sviridov D; Chin-Dusting J; Nestel P; Kingwell B; Hoang A; Olchawa B; Starr J; Dart A
    Transplantation; 2006 Feb; 81(3):361-6. PubMed ID: 16477221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified HDL: biological and physiopathological consequences.
    Norata GD; Pirillo A; Catapano AL
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):371-86. PubMed ID: 16829346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
    Walldius G; Jungner I
    Curr Opin Cardiol; 2007 Jul; 22(4):359-67. PubMed ID: 17556890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply: potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells.
    Strong TD; Champion HC; Kadowitz PJ; Bivalacqua TJ
    Int J Impot Res; 2007; 19(5):530. PubMed ID: 17786157
    [No Abstract]   [Full Text] [Related]  

  • 11. Human vascular smooth muscle cells and endothelial cells cocultured on polyglycolic acid (70/30) scaffold in tissue engineered vascular graft.
    Wen SJ; Zhao LM; Wang SG; Li JX; Chen HY; Liu JL; Liu Y; Luo Y; Changizi R
    Chin Med J (Engl); 2007 Aug; 120(15):1331-5. PubMed ID: 17711739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt.
    Ye C; Bai L; Yan ZQ; Wang YH; Jiang ZL
    Clin Biomech (Bristol, Avon); 2008; 23 Suppl 1():S118-24. PubMed ID: 17928113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells.
    Song YS; Lee HJ; Park IH; Kim WK; Ku JH; Kim SU
    Int J Impot Res; 2007; 19(4):378-85. PubMed ID: 17460699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL cholesterol, Part I: protecting your heart and arteries.
    Harv Mens Health Watch; 2007 Aug; 12(1):4-6. PubMed ID: 18018320
    [No Abstract]   [Full Text] [Related]  

  • 15. The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
    Holven KB; Aukrust P; Retterstøl K; Otterdal K; Bjerkeli V; Ose L; Nenseter MS; Halvorsen B
    J Nutr; 2008 Nov; 138(11):2070-5. PubMed ID: 18936200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL cholesterol, Part II. How to get more of a good thing.
    Harv Mens Health Watch; 2007 Sep; 12(2):1-4. PubMed ID: 18217261
    [No Abstract]   [Full Text] [Related]  

  • 17. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells.
    Norata GD; Marchesi P; Pirillo A; Uboldi P; Chiesa G; Maina V; Garlanda C; Mantovani A; Catapano AL
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):925-31. PubMed ID: 18218986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein.
    Shah PK
    Am J Cardiol; 2007 Dec; 100(11 A):S62-7. PubMed ID: 18047855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.
    Cutri BA; Hime NJ; Nicholls SJ
    Cell Res; 2006 Oct; 16(10):799-808. PubMed ID: 17016470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The double jeopardy of HDL.
    Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Hama S; Hough G; Bachini E; Grijalva VR; Wagner AC; Shaposhnik Z; Fogelman AM
    Ann Med; 2005; 37(3):173-8. PubMed ID: 16019715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.